In summary, considering the high expression of ADM in the majority of tumors and its significant association with tumor progression and poor prognosis, therapeutic interventions targeting ADM and its associated signaling pathways have demonstrated substantial anti-tumor efficacy. This evidence concerns the gene ADM and neoplasm.